Michel Finance Oct 09, 2018 Save for later Michel Finance is leaving his post as CEO of Theradiag, the company announced. No reason was given for his departure. Finance will stay on at Theradiag until Dec. 31. A search for his successor has begun. Breaking News New California Condor Genome Assembly Reveals High Genetic Diversity DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand New Products Posted to GenomeWeb: Bio-Rad, GP-write, Twist Bioscience, KogeneBiotech, More In Brief This Week: Pacific Biosciences, PerkinElmer, Unilabs, and More People in the News: New Appointments at Berkeley Lights, Castle Bio, IsoPlexis, More DermTech Q1 Revenues up 62 Percent The Scan Call to Look Again More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration. Not Always Trusted In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports. Identified Decades Later A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports. Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.